U.S., Feb. 8 -- ClinicalTrials.gov registry received information related to the study (NCT06814574) titled 'Pacemaker Implantation Following Transcatheter Tricuspid Valve Replacement' on Jan. 28.
Brief Summary: Transcatheter tricuspid valve replacement (TTVR) is associated with a high risk of third-degree atrioventricular block (AVB). However, the optimal pacemaker management following TTVR remains unclear. This study aims to identify an optimal therapeutic approach for pacemaker implantation in patients undergoing TTVR.
Study Start Date: Jan. 01, 2024
Study Type: OBSERVATIONAL
Condition:
AV Block Complete
Tricuspid Regurgitation (TR)
Recruitment Status: RECRUITING
Sponsor: Deutsches Herzzentrum Muenchen
Published by HT Digital Cont...